Tests of marker associations for family 8 (91 sons) indicated an association with a microsatellite marker located near the telomere of chromosome 27.
Antibody microarrays may have a fundamental importance in testing of marker combinations and future application in diagnostics of tumorous diseases.
However, the χ-tests of marker pairs in hybrids with N. vitripennis cytoplasm revealed a significant deviation from the expected values for marker pair Nv306 (chromosome-2) and Nv339 (chromosome-4) (χ=12.778).
Guidelines for the treatment of patients with chronic kidney disease recommend laboratory testing of markers of bone metabolism, including intact parathyroid hormone, calcium, and phosphorus.
As shown in the part below the diagonal of Table 1, we observed linkage disequilibrium for all pairwise tests of markers DXS1012, DXS1002, DXS225, DXS1019 and DXS8114 (Table 1).
The reason for the discrepancy between this study and earlier ones may be the testing of markers in a limited number of individuals.
Simultaneous testing of markers in both genes was significant in the joint all-flocks analysis: TMEM154 (P = 0.016) and CCR5 (P = 0.023).
As a stepwise testing might reduce costs compared to a simultaneous testing of markers, we simulated the performance of stepwise testing for the two-marker combinations with the highest accuracy.
The advantage of the chips is that they remove the need for time-consuming development, selection, and testing of markers for each study and provide a standard set of markers with known location, allowing direct comparisons between studies.
Also, validation of new biomarkers in clinical practice and testing of markers as predictive factors for endpoints, such as LOS, needed for renal replacement therapy, mechanical ventilation time, and mortality are necessary.
This pairwise test of the markers yielded results consistent with the previous analyses (Table S4).
